Projects per year
Fingerprint
Dive into the research topics where Eric Hollander is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 48 Finished
-
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]
9/1/17 → 8/31/20
Project: Research project
-
GREATER NEW YORK AUTISM CENTER OF EXCELLENCE - CLINICAL CORE
National Center for Research Resources
3/1/07 → 2/29/08
Project: Research project
-
TOPIRAMATE IN THE TREATMENT OF PATHOLOGICAL GAMBLING
National Center for Research Resources
3/1/07 → 2/29/08
Project: Research project
-
DIVALPROEX SODIUM ER IN ADULT AUTISM
National Center for Research Resources
3/1/07 → 2/29/08
Project: Research project
-
OXYTOCIN VS PLACEBO ON RESPONSE INHIBITION AND FACE PROCESSING IN AUTISM
National Center for Research Resources
3/1/07 → 2/29/08
Project: Research project
-
Lessons from a multicenter, international, large sample size analysis of patients with obsessive-compulsive disorders: An overview of the ICOCS Snapshot studies
Vismara, M., Benatti, B., Fineberg, N. A., Hollander, E., Van Ameringen, M., Menchon, J. M., Zohar, J. & Dell'Osso, B., Feb 11 2024, In: CNS spectrums. 29, 1, p. 40-48 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach
Pallanti, S., Zohar, J., Kasper, S., Möller, H. J. & Hollander, E., Feb 2024, In: Journal of Psychiatric Research. 170, p. 65-72 8 p.Research output: Contribution to journal › Review article › peer-review
-
Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder
Tobe, R., Zhu, Y., Gleissl, T., Rossomanno, S., Veenstra-VanderWeele, J., Smith, J. & Hollander, E., Jul 2023, In: Neuropsychopharmacology. 48, 8, p. 1201-1216 16 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The role of ketogenic therapy in developmental disorders
Taoulost, S., Rasgon, N., Ferretti, C. J. & Hollander, E., May 2023, In: Journal of Psychiatric Research. 161, p. 307-309 3 p.Research output: Contribution to journal › Article › peer-review
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders–Version 3. Part I: Anxiety disorders
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., Hollander, E., Kaiya, H., Karavaeva, T., Kasper, S., Katzman, M., Kim, Y. K., Inoue, T., Lim, L., Masdrakis, V., Menchón, J. M., & 13 others , 2023, In: World Journal of Biological Psychiatry. 24, 2, p. 79-117 39 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations